Open Access

Combined treatment with niclosamide ethanolamine and artemether combination improves type 1 diabetes via the targeting of liver mitochondria

  • Authors:
    • Wenci Weng
    • Honghong Liu
    • Zhijian Sun
    • Peng Zhou
    • Xuewen Yu
    • Mumin Shao
    • Pengxun Han
    • Huili Sun
  • View Affiliations

  • Published online on: January 25, 2022     https://doi.org/10.3892/etm.2022.11164
  • Article Number: 239
  • Copyright: © Weng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Type 1 diabetes (T1D) is characterized by dysregulated blood glucose and liver metabolism. In previous studies, niclosamide ethanolamine salt (NEN) and artemether (Art) displayed significant hypoglycemic effects. However, their combined therapeutic effects on the liver in T1D have remained elusive. In the present study, T1D mice were established and randomly allocated into groups. Following treatment, the physiological and metabolic parameters, including liver function, glycogen content, glucose‑6‑phosphatase (G6Pase) protein expression levels, mitochondrial biogenesis and mitochondrial metabolism were analyzed. Compared with the NEN or Art treatments alone, their combination improved glycometabolism and the symptoms of diabetes. Combined treatment with NEN and Art also significantly ameliorated liver injury and increased liver glycogen storage. Furthermore, combinatorial treatment significantly downregulated hepatic G6Pase protein expression levels and regulated mitochondrial biogenesis. NEN and Art increased the respiratory exchange rate and reduced mitochondrial phosphoenolpyruvate carboxykinase and branched‑chain α‑keto acid dehydrogenase complex protein expression levels, whereby the effects were obviously enhanced by their application as a combined treatment. In conclusion, the present study confirmed that combined treatment with NEN and Art improved glycometabolism and liver function in T1D mice and the therapeutic effects may be partially associated with the regulation of liver mitochondria.
View Figures
View References

Related Articles

Journal Cover

March-2022
Volume 23 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Weng W, Liu H, Sun Z, Zhou P, Yu X, Shao M, Han P and Sun H: Combined treatment with niclosamide ethanolamine and artemether combination improves type 1 diabetes via the targeting of liver mitochondria. Exp Ther Med 23: 239, 2022
APA
Weng, W., Liu, H., Sun, Z., Zhou, P., Yu, X., Shao, M. ... Sun, H. (2022). Combined treatment with niclosamide ethanolamine and artemether combination improves type 1 diabetes via the targeting of liver mitochondria. Experimental and Therapeutic Medicine, 23, 239. https://doi.org/10.3892/etm.2022.11164
MLA
Weng, W., Liu, H., Sun, Z., Zhou, P., Yu, X., Shao, M., Han, P., Sun, H."Combined treatment with niclosamide ethanolamine and artemether combination improves type 1 diabetes via the targeting of liver mitochondria". Experimental and Therapeutic Medicine 23.3 (2022): 239.
Chicago
Weng, W., Liu, H., Sun, Z., Zhou, P., Yu, X., Shao, M., Han, P., Sun, H."Combined treatment with niclosamide ethanolamine and artemether combination improves type 1 diabetes via the targeting of liver mitochondria". Experimental and Therapeutic Medicine 23, no. 3 (2022): 239. https://doi.org/10.3892/etm.2022.11164